This Is Too Hot For Biogen Inc (NASDAQ: BIIB), Let’s Take A Closer Look

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, BIIB falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. The current market capitalization of Biogen Inc is $22.09B. A total of 1.16 million shares were traded on the day, compared to an average of 1.53M shares.

In the most recent transaction, Singhal Priya sold 110 shares of BIIB for 157.21 per share on Dec 09 ’24. After the transaction, the Head of Development now owns 5,426 company shares. In a previous transaction on Dec 09 ’24, Singhal Priya bought 110 shares at 157.21 per share.

Among the insiders who sold shares, Singhal Priya disposed of 431 shares on Sep 03 ’24 at a per-share price of $204.22. This resulted in the Head of Development holding 5,316 shares of BIIB after the transaction. In another insider transaction, Singhal Priya bought 431 shares at $204.22 per share on Sep 03 ’24.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BIIB has a high of $268.30 and a low of $145.07.

As of this writing, BIIB has an earnings estimate of $3.43 per share for the current quarter. EPS was calculated based on a consensus of 27.0 estimates, with a high estimate of $3.85 per share and a lower estimate of $3.13.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BIIB’s latest balance sheet shows that the firm has $3.80B in Cash & Short Term Investments as of fiscal 2021. There were $7.60B in debt and $4.30B in liabilities at the time. Its Book Value Per Share was $112.28, while its Total Shareholder’s Equity was $10.96B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BIIB is Buy with a score of 4.00.

Most Popular

Related Posts